ID27812A - ESTER PENGHAMBAT sPLA2 - Google Patents

ESTER PENGHAMBAT sPLA2

Info

Publication number
ID27812A
ID27812A IDW20002216A ID20002216A ID27812A ID 27812 A ID27812 A ID 27812A ID W20002216 A IDW20002216 A ID W20002216A ID 20002216 A ID20002216 A ID 20002216A ID 27812 A ID27812 A ID 27812A
Authority
ID
Indonesia
Prior art keywords
spla2
ester inhibitors
ester
inhibitors
compound
Prior art date
Application number
IDW20002216A
Other languages
English (en)
Indonesian (id)
Inventor
Michael Lyle Denney
John M Morin Jr
Daniel Jon Sall
Jason Scott Sawyer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID27812A publication Critical patent/ID27812A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW20002216A 1998-05-01 1999-04-20 ESTER PENGHAMBAT sPLA2 ID27812A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8387398P 1998-05-01 1998-05-01

Publications (1)

Publication Number Publication Date
ID27812A true ID27812A (id) 2001-04-26

Family

ID=22181214

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002216A ID27812A (id) 1998-05-01 1999-04-20 ESTER PENGHAMBAT sPLA2

Country Status (22)

Country Link
EP (1) EP1073440B1 (es)
JP (1) JP4459441B2 (es)
KR (1) KR20010071197A (es)
CN (1) CN1303290A (es)
AT (1) ATE280155T1 (es)
AU (1) AU755901B2 (es)
BR (1) BR9910149A (es)
CA (1) CA2331036A1 (es)
DE (1) DE69921314T2 (es)
EA (1) EA003277B1 (es)
ES (1) ES2230847T3 (es)
HR (1) HRP20000738A2 (es)
HU (1) HUP0201636A1 (es)
ID (1) ID27812A (es)
IL (1) IL139203A0 (es)
NO (1) NO315940B1 (es)
NZ (1) NZ507391A (es)
PL (1) PL344571A1 (es)
SK (1) SK16332000A3 (es)
TR (1) TR200003198T2 (es)
WO (1) WO1999056752A1 (es)
ZA (1) ZA200005561B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140327A (en) * 1999-05-12 2000-10-31 Eli Lilly And Company Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
WO2001044185A1 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Carbon monoxide-based synthesis of spla2 inhibitors
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
CA2686157A1 (en) * 2007-05-03 2008-11-13 Joaquim Trias Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapies
US8048880B2 (en) 2007-05-03 2011-11-01 Anthera Pharmaceuticals, Inc. Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies
US20150335498A1 (en) * 2014-05-22 2015-11-26 The Procter & Gamble Company Heterogenous mass containing foam
US10729600B2 (en) 2015-06-30 2020-08-04 The Procter & Gamble Company Absorbent structure
US11173078B2 (en) 2015-11-04 2021-11-16 The Procter & Gamble Company Absorbent structure
PL3370664T3 (pl) 2015-11-04 2022-03-07 The Procter & Gamble Company Wyrób chłonny zawierający strukturę chłonną

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
RU2128169C1 (ru) * 1994-04-01 1999-03-27 Эли Лилли Энд Компани Iн-индол-3-глиоксиламиды, ингибирующие spla2-медиируемое выделение жирных кислот, фармацевтическая композиция
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
DK0832066T3 (da) * 1995-06-06 2001-11-19 Pfizer Substituerede N-(indol-2-carbonyl)amider og derivater som glycogenphosphorylaseinhibitorer
CA2358492A1 (en) * 1998-12-21 2000-06-29 Eli Lilly And Company Combination therapy for the treatment of sepsis

Also Published As

Publication number Publication date
EA200001141A1 (ru) 2001-04-23
NZ507391A (en) 2003-12-19
CA2331036A1 (en) 1999-11-11
DE69921314T2 (de) 2006-02-09
JP4459441B2 (ja) 2010-04-28
TR200003198T2 (tr) 2001-03-21
ATE280155T1 (de) 2004-11-15
NO315940B1 (no) 2003-11-17
BR9910149A (pt) 2001-10-02
WO1999056752A1 (en) 1999-11-11
JP2002513761A (ja) 2002-05-14
AU3652599A (en) 1999-11-23
HUP0201636A1 (en) 2002-09-28
NO20005477D0 (no) 2000-10-31
IL139203A0 (en) 2001-11-25
ZA200005561B (en) 2002-01-10
EP1073440A1 (en) 2001-02-07
HRP20000738A2 (en) 2001-10-31
NO20005477L (no) 2000-10-31
PL344571A1 (en) 2001-11-05
AU755901B2 (en) 2003-01-02
KR20010071197A (ko) 2001-07-28
ES2230847T3 (es) 2005-05-01
EP1073440B1 (en) 2004-10-20
EA003277B1 (ru) 2003-04-24
EP1073440A4 (en) 2002-07-17
SK16332000A3 (sk) 2001-06-11
CN1303290A (zh) 2001-07-11
DE69921314D1 (de) 2004-11-25

Similar Documents

Publication Publication Date Title
DE69830335D1 (de) MORPHOLINO-N-ETHYL ESTER PRODROGEN VON INDOL sPLA 2 HEMMER
AU2003284871A1 (en) Translating detected wafer defect coordinates
ID27812A (id) ESTER PENGHAMBAT sPLA2
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
NO20015650D0 (no) Pyrrolotriazin-inhibitorer for kinaser
TR200200129T2 (tr) Hepatit C inhibitörü tri-peptidler
NO20014642D0 (no) Aminopyrimidiner som sorbitol-dehydrogenase-inhibitorer
AU2001274009A1 (en) Substituted indoles as parp inhibitors
CL2011001971A1 (es) Uso de compuestos derivados del estereoisomero (-) del acido 3-trihalometilfenoxi) (4-halofenil)acetico para el tratamiento de la hiperuricemia. (divisional sol. 1444-00).
AU2003260345A1 (en) 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
ATE392206T1 (de) Indolderivate als beta-2 agonisten
ITMI20021620A1 (it) Composto ad ativita' antitumorale
NO20003451D0 (no) 2,3-substituerte indolforbindelser som cox-2 inhibitorer
UY27632A1 (es) Metabolitos del ácido (3-((4- terc- butilbencil)-piridin.3- sulfonil) amino) metil ) fenoxi) acético
AU5331499A (en) Indole spla2 inhibitors
HUP0102812A3 (en) Pharmaceutical compositions containing the phospholipase inhibitor sodium {[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1h-indol-4-yl]oxy}acetate and process for pruducing them
JP2002513761A5 (es)
NO995457L (no) Fremgangsmåte ved fremstilling av sertindol
NO20005783L (no) Prosess for å detektere objekter i bevegelse med aktiv sonar
DK0888340T3 (da) 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin
AU1279899A (en) N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors
BR0010448A (pt) éster de morfolino-n-etila derivado de um inibidor de spla2 de indol
MY142634A (en) Method for synthesis of (2s,3as,7as)-perhydroindole-2-carboxylic acid and esters thereof, and use in the synthesis of perindopril
AU2002237655A1 (en) Substituted benzoindoles as spla2 inhibitors
CA2337382A1 (en) Process for the preparation of an indole derivative